Biotech Values

[onco_investor]

ASCO 2010 Posters Listed for Reovirus-ONCY

Greetings to the board, nice job Dew. How do we think ASCO will go for ONCY this year?

http://meetingplanner.asco.org/
Search Keyword - Reovirus

Developmental Therapeutics - Experimental Therapeutics
Monday, June 7 at 8:00 AM - 12:00 PM

S Hall A2

#3080: A phase I/II study of oncolytic reovirus plus carboplatin/ paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck (SCCHN).

Eleni M Karapanagiotou


Clinical Trials, Special Session - Trials in Progress Poster Session
Monday, June 7 at 8:00 AM - 12:00 PM

S Hall A2

#TPS253: Phase I/II trial of reovirus serotype 3-Dearing strain in patients with recurrent ovarian cancer.

David E. Cohn, MD

#TPS292: Phase II study of reovirus with paclitaxel (P) and carboplatin (C) in patients with metastatic non-small cell lung cancer (NSCLC) who have Kras or EGFR-activated tumors.

Elaine Tat Lam

Interim Results?